Signal transduction inhibition: Results from phase I clinical trials in chronic myeloid leukemia

被引:30
作者
Druker, B [1 ]
机构
[1] Oregon Hlth Sci Univ, Dept Med, Div Hematol & Med Oncol, Portland, OR 97201 USA
关键词
D O I
10.1053/shem.2001.27079
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:9 / 14
页数:6
相关论文
共 15 条
[1]  
Buchdunger E, 1996, CANCER RES, V56, P100
[2]   CGP 57148, a tyrosine kinase inhibitor, inhibits the growth of cells expressing BCR-ABL, TEL-ABL, and TEL-PDGFR fusion proteins [J].
Carroll, M ;
OhnoJones, S ;
Tamura, S ;
Buchdunger, E ;
Zimmermann, J ;
Lydon, NB ;
Gilliland, DG ;
Druker, BJ .
BLOOD, 1997, 90 (12) :4947-4952
[3]   INDUCTION OF CHRONIC MYELOGENOUS LEUKEMIA IN MICE BY THE P210BCR/ABL GENE OF THE PHILADELPHIA-CHROMOSOME [J].
DALEY, GQ ;
VANETTEN, RA ;
BALTIMORE, D .
SCIENCE, 1990, 247 (4944) :824-830
[4]   The tyrosine kinase inhibitor CGP57148B selectively inhibits the growth of BCR-ABL-positive cells [J].
Deininger, MWN ;
Goldman, JM ;
Lydon, N ;
Melo, JV .
BLOOD, 1997, 90 (09) :3691-3698
[5]   Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the philadelphia chromosome. [J].
Druker, BJ ;
Sawyers, CL ;
Kantarjian, H ;
Resta, DJ ;
Reese, SF ;
Ford, JM ;
Capdeville, R ;
Talpaz, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1038-1042
[6]   Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells [J].
Druker, BJ ;
Tamura, S ;
Buchdunger, E ;
Ohno, S ;
Segal, GM ;
Fanning, S ;
Zimmermann, J ;
Lydon, NB .
NATURE MEDICINE, 1996, 2 (05) :561-566
[7]   Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. [J].
Druker, BJ ;
Talpaz, M ;
Resta, DJ ;
Peng, B ;
Buchdunger, E ;
Ford, JM ;
Lydon, NB ;
Kantarjian, H ;
Capdeville, R ;
Ohno-Jones, S ;
Sawyers, CL .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1031-1037
[8]  
Faderl S, 1999, ONCOLOGY-NY, V13, P169
[9]   Inhibition of the ABL kinase activity blocks the proliferation of BCR/ABL(+) leukemic cells and induces apoptosis [J].
GambacortiPasserini, C ;
leCoutre, P ;
Mologni, L ;
Fanelli, M ;
Bertazzoli, C ;
Marchesi, E ;
DiNicola, M ;
Biondi, A ;
Corneo, GM ;
Belotti, D ;
Pogliani, E ;
Lydon, NB .
BLOOD CELLS MOLECULES AND DISEASES, 1997, 23 (19) :380-394
[10]   ACUTE-LEUKEMIA IN BCR/ABL TRANSGENIC MICE [J].
HEISTERKAMP, N ;
JENSTER, G ;
TENHOEVE, J ;
ZOVICH, D ;
PATTENGALE, PK ;
GROFFEN, J .
NATURE, 1990, 344 (6263) :251-253